TickerFacts.

Company research / XLAB

Exascale Labs Holdings Inc. (XLAB)

Also trades as XLABW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

CIK 0002109869

For the year ended 2026-06-30, Exascale Labs Holdings Inc. reported revenue of $14.82M. Revenue grew 111.3% from the prior annual period.

Key ratios (year ended 2026-06-30)

16.3%
Gross margin
-32.4%
Operating margin
-82.1%
Net margin
111.3%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-09-08

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-30
Revenue$14.82M$7.02M
Cost of Revenue$12.40M$5.91M
Gross Profit$2.42M$1.11M
R&D Expense$5.49M$2.80M
Operating Income-$4.80M-$3.04M
Net Income-$12.16M-$7.66M
EPS (Diluted)-$8108.26-$5106.44
Total Assets$6.73M$7.32M
Total Liabilities$31.89M$20.32M
Shareholders' Equity-$25.16M-$13.00M
Cash & Equivalents$2.69M$4.23M
Operating Cash Flow-$2.75M-$1.01M
Capital Expendituresn/a$2.1K
Free Cash Flown/a-$1.01M
Shares Outstandingn/a1.5K
Weighted Average Diluted Shares1.5K1.5K
EPS (Basic)-$8108.26-$5106.44